Interleukin-28B Polymorphism is a Pharmacogenetic Predictor during Sofosbuvir Plus Pegylated Interferon and Ribavirin Therapy for Chronic Hepatitis C Egyptian Patients

Hosni Dh Abd EL-Raheem^1*, Medhat H Hashem², Alaa A Hemeida², Mohamed E Ebeed², Usama A Arafa³ and Laila M Yousef⁴

¹Department of Medical Investigations, Sohag General Hospital, Sohag, Egypt

²Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Menoufia, Egypt

³Department of Internal Medicine, Faculty of Medicine, Sohag University, Sohag, Egypt

⁴Department of Clinical Pathology, Faculty of Medicine, Sohag University, Sohag, Egypt